Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Natural history of hepatitis B or C is comprised of multiple milestones such as liver cirrhosis and liver cancer. To fully characterize its natural course, semicompeting risks represent a common problem where liver cirrhosis and liver cancer are both of interest, but only the former may be censored by the latter. Copula, frailty and multistate models serve as well-established analytics for semicompeting risks. Here, we cast the semicompeting risks in a mediation framework, with liver cirrhosis as a mediator and liver cancer as an outcome. We define the indirect and direct effects as the effects of an exposure on the liver cancer incidence mediated and not mediated through liver cirrhosis, respectively. With the estimands derived as conditional probabilities, we derive respective expressions under the copula, frailty, and multistate models. Next, we propose estimators based on nonparametric maximum likelihood or U-statistics and establish their asymptotic results. Numerical studies demonstrate that the efficiency of copula models leads to potential bias due to model misspecification. Moreover, the robustness of frailty models is accompanied by a loss in efficiency, and multistate models balance the efficiency and robustness. We demonstrate the utility of the proposed methods by a hepatitis study, showing that hepatitis B and C lead to a higher incidence of liver cancer by increasing liver cirrhosis incidence. Thus, mediation modeling provides a unified framework that accommodates various semicompeting risks models.

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.9862DOI Listing

Publication Analysis

Top Keywords

semicompeting risks
20
liver cirrhosis
20
liver cancer
20
multistate models
12
liver
10
natural history
8
mediation modeling
8
cirrhosis liver
8
copula frailty
8
frailty multistate
8

Similar Publications

A multistate transition model for survival estimation in randomized trials with treatment switching and a cured subgroup.

BMC Med Res Methodol

August 2025

Department of Health Statistics, School of Preventive Medicine, Fourth Military Medical University, Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, No.169 Changlexilu Road, Xi'an, Shaanxi, 710032, China.

Although many methods have been proposed on the overall survival estimation in randomized trials permitting treatment switching after the progressive disease (PD), the cured subgroup of patients within these trials has not been fully considered. These cured patients would never experience PD and subsequent risk of treatment switching, yet they may suffer death hazard similar to those without the disease. Due to the mix of the cured subgroup, existing methods may yield biased effect estimation for the uncured patients between treatment groups.

View Article and Find Full Text PDF

Introduction: Sleep difficulty, a prevalent sleep disturbance in ageing populations, has shown paradoxical associations with dementia risk in prior epidemiological studies. Emerging evidence suggests that survival bias-where premature mortality in individuals with sleep difficulty obscures dementia risk-may explain these inconsistencies.

Methods: We analysed data from 457,367 UK Biobank participants aged 40-69 years who were enrolled at baseline between 2006 and 2010 and followed until 2022.

View Article and Find Full Text PDF

In the realm of clinical medical research, semi-competing risks data are usually observed in practice, yet there are few studies on the joint models of longitudinal and semi-competing risks data. In this paper, a joint model for longitudinal and semi-competing risks data is proposed. Based on the expectile regression, a linear mixed-effects longitudinal sub-model is formulated, and a Cox proportional hazards survival sub-model is considered under the framework of semi-competing risks.

View Article and Find Full Text PDF

Objective: We examined choice of outpatient epilepsy-specific antiseizure medication (ESM) after a stroke discharge and outcomes in a sample of US older adults.

Methods: In this matched cohort study, we analyzed a 20% sample of US Medicare beneficiaries aged 65 years and older hospitalized for acute ischemic stroke (AIS) between 2009 and 2021 who were discharged home. Individuals met insurance coverage criteria and were not taking ESM before hospitalization.

View Article and Find Full Text PDF

We are interested in how patients with hepatitis B progress to liver cirrhosis (an intermediate outcome) and liver cancer (a primary outcome). The separable effect has recently been proposed to study causal effects in the setting of competing risks. In this work, we extend the separable effect approach to semicompeting risks involving a primary and intermediate outcome.

View Article and Find Full Text PDF